BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10433623)

  • 1. Evidence for the colonic origin of ovarian cancer cell line SW626.
    Furlong MT; Hough CD; Sherman-Baust CA; Pizer ES; Morin PJ
    J Natl Cancer Inst; 1999 Aug; 91(15):1327-8. PubMed ID: 10433623
    [No Abstract]   [Full Text] [Related]  

  • 2. Hereditary colon cancer genes.
    Grady WM; Markowitz SD
    Methods Mol Biol; 2003; 222():59-83. PubMed ID: 12710680
    [No Abstract]   [Full Text] [Related]  

  • 3. New kind of cancer mutation found.
    Gura T
    Science; 1997 Aug; 277(5330):1201-2. PubMed ID: 9297236
    [No Abstract]   [Full Text] [Related]  

  • 4. Rare activation of the TCF/beta-catenin pathway in ovarian cancer.
    Furlong MT; Morin PJ
    Gynecol Oncol; 2000 Apr; 77(1):97-104. PubMed ID: 10739697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flies in the colon.
    Berry C
    QJM; 2002 Jul; 95(7):487-8. PubMed ID: 12096154
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current data on the role of APC protein in the origin of colorectal cancer].
    Bonneton C; Larue L; Thiery JP
    Bull Cancer; 1997 Nov; 84(11):1053-60. PubMed ID: 9536987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline mutations in the beta-catenin gene are not associated with the FAP phenotype without an APC mutation.
    Dobbie Z; Müller H
    J Med Genet; 1999 Jul; 36(7):573-4. PubMed ID: 10424823
    [No Abstract]   [Full Text] [Related]  

  • 8. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
    Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
    Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
    Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
    Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation of alpha-catenin results in invasiveness of human HCT-8 colon cancer cells.
    Vermeulen SJ; Nollet F; Teugels E; Philippe J; Speleman F; van Roy FM; Bracke ME; Mareel MM
    Ann N Y Acad Sci; 1997 Dec; 833():186-9. PubMed ID: 9616753
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer. A CINtillating new job for the APC tumor suppressor.
    Pellman D
    Science; 2001 Mar; 291(5513):2555-6. PubMed ID: 11286276
    [No Abstract]   [Full Text] [Related]  

  • 12. Early gastric cancer development in a familial adenomatous polyposis patient.
    Shimoyama S; Aoki F; Kawahara M; Yahagi N; Motoi T; Kuramoto S; Kaminishi M
    Dig Dis Sci; 2004 Feb; 49(2):260-5. PubMed ID: 15104367
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway.
    Mirabelli-Primdahl L; Gryfe R; Kim H; Millar A; Luceri C; Dale D; Holowaty E; Bapat B; Gallinger S; Redston M
    Cancer Res; 1999 Jul; 59(14):3346-51. PubMed ID: 10416591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [From gene to disease; the APC gene and familial adenomatous polyposis coli].
    van der Luijt RB; Tops CM; Vasen HF
    Ned Tijdschr Geneeskd; 2000 Oct; 144(42):2007-9. PubMed ID: 11072519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-cadherin expression is homogeneously reduced in adenoma from patients with familial adenomatous polyposis: an immunohistochemical study of E-cadherin, beta-catenin and cyclooxygenase-2 expression.
    Jungck M; Grünhage F; Spengler U; Dernac A; Mathiak M; Caspari R; Friedl W; Sauerbruch T
    Int J Colorectal Dis; 2004 Sep; 19(5):438-45. PubMed ID: 14986031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation and expression of the beta-catenin-interacting protein ICAT in human colorectal tumors.
    Koyama T; Tago K; Nakamura T; Ohwada S; Morishita Y; Yokota J; Akiyama T
    Jpn J Clin Oncol; 2002 Sep; 32(9):358-62. PubMed ID: 12417602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic targets of beta-catenin-mediated transcription in molecular pathogenesis of intestinal polyposis.
    Watson SA
    Lancet; 2001 Feb; 357(9256):572-3. PubMed ID: 11558478
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic evidence that juvenile nasopharyngeal angiofibroma is an integral FAP tumour.
    Valanzano R; Curia MC; Aceto G; Veschi S; De Lellis L; Catalano T; La Rocca G; Battista P; Cama A; Tonelli F; Mariani-Costantini R
    Gut; 2005 Jul; 54(7):1046-7. PubMed ID: 15951557
    [No Abstract]   [Full Text] [Related]  

  • 19. A mammalian two-hybrid system for adenomatous polyposis coli-mutated colon cancer therapeutics.
    Wakita K; Tetsu O; McCormick F
    Cancer Res; 2001 Feb; 61(3):854-8. PubMed ID: 11221869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells.
    Roh H; Green DW; Boswell CB; Pippin JA; Drebin JA
    Cancer Res; 2001 Sep; 61(17):6563-8. PubMed ID: 11522655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.